Chunkyu Ko

Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions

A genome-wide CRISPR screen identifies UFMylation and TRAMP-like complexes as host factors required for hepatitis A virus infection

A robust cell culture system supporting the complete life cycle of hepatitis B virus

Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors

Gut microbiota and Covid-19- possible link and implications

Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA

Identification and characterization of a novel bipartite nuclear localization signal in the hepatitis B virus polymerase

Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA

PAPD5/7 Are Host Factors That Are Required for Hepatitis B Virus RNA Stabilization

DEAD-Box Helicases: Sensors, Regulators, and Effectors for Antiviral Defense

Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20

DEAD-box helicases: the Yin and Yang roles in viral infections

Hydrophobic residues of terminal protein domain of hepatitis B virus polymerase contribute to distinct steps in viral genome replication

Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels

Novel viral and host targets to cure hepatitis B

DDX3 DEAD-Box RNA Helicase Is a Host Factor That Restricts Hepatitis B Virus Replication at the Transcriptional Level

The FDA-Approved Drug Irbesartan Inhibits HBV-Infection in HepG2 Cells Stably Expressing Sodium Taurocholate Co-Transporting Polypeptide